We focused solely on assessing p-tau associations with verbal episodic memory decline because it is widely recognized as one of the earliest and most prominent clinical features of early AD.35 However, memory decline alone does not fully capture the broader cognitive and functional decline that occurs throughout the disease course, which we acknowledge as a limitation of our study. The gene discussed is MAPT; the disease is Alzheimer disease.